Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Eastbourne District General Hospital Eastbourne, United Kingdom
  • St James University Hospital Leeds, United Kingdom
  • The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom
View Trial Details
Recruiting

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

NCT06182774

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 28 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions
Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details

Related conditions